Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system. - Wikidata - wikimedia - TriplyDB

Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.

Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.

http://www.wikidata.org/entity/Q54447289

about

Molecular characteristics and predictors of survival in patients with malignant neuroendocrine tumors.Insulin secretion and insulin-producing tumors Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors.Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon-rectum.O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.Cervical neuroendocrine tumor in a young female with Lynch Syndrome.Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents Molecular pathology of pancreatic neuroendocrine tumors.Histopathology of gastrointestinal neuroendocrine neoplasms.Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.NETs: organ-related epigenetic derangements and potential clinical applications.Four tumours including neuroendocrine tumour of the ileum.Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors.Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.

P2860

Q33775632-7792C91B-874B-4009-821E-FBBDFC21FD0C Q33786707-1C8E4E20-8D35-40C2-81B6-11AA79EA0BFD Q33991964-B2E0112F-99C9-4F20-8A5B-AED99E614E22 Q34084289-5E5A20B9-7524-4864-B035-237C0022BCE1 Q34504432-28C6F41D-1452-40F0-9187-D0C2C14FD6EF Q35001754-C55CB92A-DEF3-4CDC-A03D-3D6CE82D4D8E Q35019094-64C5DEDD-C024-43F3-AFA5-F9D653D39231 Q35478014-2004C193-F847-43D0-AA00-4F99C49C908A Q35677887-509E8B76-847E-403B-A622-697779CD075E Q36162528-59E27523-F4E1-460C-8554-86F38F103823 Q36551032-43AC2895-199E-41A8-B1EF-445435AA2BEF Q37997894-5D60C696-4C92-42B7-8D4E-0CBD0A0335BC Q38272919-F033635A-565C-4F7F-9A95-910571DE3D85 Q38841735-5ECA0D2C-CC04-45BE-9F2B-C3B23A370747 Q40749432-8E612C9C-1696-4B55-9400-A3F522FCC65E Q42115029-2CE74DB0-ED71-4E7B-A22B-518128FC41D5 Q42132289-A6362E6F-BB7B-47DF-A7E4-F29282BCD360 Q47131115-E8582504-9376-4797-BE48-43C988309A60 Q48295398-3F4C7731-3AA4-40F1-8FED-3A54D82AD685 Q48306172-3365ACD9-1EF9-447C-9E44-7627AFCAC58F Q53225327-242FBB17-F4B7-4472-80EE-848A3C4B9EDB

P2860

Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.

http://www.wikidata.org/entity/Q54447289

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Analysis of molecular pathways ...... stro-entero-pancreatic system.

@en

Analysis of molecular pathways ...... stro-entero-pancreatic system.

@nl

type

label

Analysis of molecular pathways ...... stro-entero-pancreatic system.

@en

Analysis of molecular pathways ...... stro-entero-pancreatic system.

@nl

prefLabel

Analysis of molecular pathways ...... stro-entero-pancreatic system.

@en

Analysis of molecular pathways ...... stro-entero-pancreatic system.

@nl

P1433

Q54447289-323FEE12-2F90-481F-8876-B99CADA24769

P1476

Q54447289-9A5BAE3B-01E2-4D66-9116-336A67E3D19B

P2093

Q54447289-29DE54F8-9362-42EF-AD3F-96B6555D5BDE

Q54447289-732CCC4A-6CD7-4A9D-8E58-58095BBE7AFA

Q54447289-7797C11B-3618-407A-BF91-4A6E352E980D

Q54447289-94950EDC-6DB1-46C4-9513-59D82723C686

Q54447289-FA68D155-4C5D-4143-880E-2A8C8AAE1F76

P2860

Q54447289-0B8A9F9C-F34B-4415-A4A8-9BDF28367731

Q54447289-11914DCE-8CED-4C4B-8AB8-FFC813A93916

Q54447289-19448F13-F85B-443D-A115-44ACD7EB0A41

Q54447289-1BAA01FF-611B-4A14-A3A7-0D524D886EEA

Q54447289-1C8969F2-2FFD-4606-9451-202002383682

Q54447289-21919450-4003-4EE4-B2CA-1FD51B769D49

Q54447289-2A79C717-A557-442B-9CC4-B6137FA88224

Q54447289-2F6CE8D9-D2B2-48BC-9800-4F90FC4497C3

Q54447289-3DD1CF52-AEA8-4CF2-8D39-813917028533

Q54447289-409FAF84-C480-4BAB-9F73-DD592FA2F464

P304

Q54447289-73B0CDAC-CEB8-4DA2-8952-83B7D209DC14

P31

Q54447289-F7769541-DBC0-4327-B609-D975166B9389

P356

Q54447289-B8A932A6-2857-4E85-BBCD-3919939F5FA3

P433

Q54447289-922822E1-614C-4C1F-8E6F-A6D3B9F0DB9E

P478

Q54447289-8415407A-F6E7-41B0-86EE-D20852E062E0

P577

Q54447289-3E04BBF2-FC01-4B43-A9F9-1F8137349530

P5875

Q54447289-F8D3EAD8-D2E8-4C4B-B9C2-C28B33CE5ABE

P698

Q54447289-B712D77A-0956-474F-98CF-E17006CEB5F3

P356

P1433

International Journal of Cancer

P1476

Analysis of molecular pathways ...... stro-entero-pancreatic system.

@en

P2093

Andrea Sosnowski

http://www.w3.org/2001/XMLSchema#string

Annette Schmitt-Gräff

http://www.w3.org/2001/XMLSchema#string

Christian N Arnold

http://www.w3.org/2001/XMLSchema#string

Hubert E Blum

http://www.w3.org/2001/XMLSchema#string

Rudolf Arnold

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses

The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties

Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.

CpG island methylator phenotypes in aging and cancer.

A 5-decade analysis of 13,715 carcinoid tumors.

Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment.

Genetics of neuroendocrine and carcinoid tumours.

P304

2157-2164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.22569

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6526855

http://www.w3.org/2001/XMLSchema#string

P698

17278096

http://www.w3.org/2001/XMLSchema#string